Advanced search
Publication Cover
Postgraduate Medicine Volume 128, 2016 - Issue 7
Submit an article Journal homepage
208
Views
13
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study

Fabio Massimo PerrottaDipartimento di Medicina e Scienze della salute ‘Vincenzo Tiberio’, Università degli studi del Molise, Campobasso, ItalyView further author information
&
Ennio LubranoDipartimento di Medicina e Scienze della salute ‘Vincenzo Tiberio’, Università degli studi del Molise, Campobasso, ItalyCorrespondence[email protected]
View further author information
Pages 693-696 | Received 25 May 2016, Accepted 02 Aug 2016, Published online: 16 Aug 2016

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ennio Lubrano, Silvia Scriffignano & Fabio Massimo Perrotta. (2019) TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis. Expert Review of Clinical Immunology 15:12, pages 1303-1312.
Read now

Articles from other publishers (12)

Ennio Lubrano, Silvia Scriffignano & Fabio Massimo Perrotta. (2023) Patient reported outcomes in early vs late diagnosis of psoriatic arthritis. Revista Colombiana de Reumatología (English Edition) 30, pages S27-S33.
Crossref
Ennio Lubrano, Silvia Scriffignano & Fabio Massimo Perrotta. (2023) Patient reported outcomes in early vs late diagnosis of psoriatic arthritis. Revista Colombiana de Reumatología 30, pages S27-S33.
Crossref
Laura C Coates, Philip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao & Corine Gaillez. (2023) Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study. RMD Open 9:2, pages e002939.
Crossref
Andrew Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lu, Zailong Wang, Ahmed M Soliman, Ann Eldred, Lisa Barcomb & Alan Kivitz. (2022) Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial. Annals of the Rheumatic Diseases 81:3, pages 351-358.
Crossref
Ennio Lubrano, Silvia Scriffignano & Fabio Massimo Perrotta. (2020) Residual Disease Activity and Associated Factors in Psoriatic Arthritis. The Journal of Rheumatology 47:10, pages 1490-1495.
Crossref
Ennio Lubrano, Silvia Scriffignano, Ana Belen Azuaga, Julio Ramirez, Juan Canete & Fabio Massimo Perrotta. (2020) Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices. RMD Open 6:1, pages e001170.
Crossref
Ennio Lubrano, Fabio Massimo Perrotta, Silvia Scriffignano, Laura C. Coates & Philip Helliwell. (2019) Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients. Rheumatology and Therapy 6:4, pages 521-528.
Crossref
Ruben Queiro, Juan D. Cañete, Carlos Montilla, Miguel Angel Abad, María Montoro, Susana Gómez & Ana Cábez. (2019) Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis. The Journal of Rheumatology 46:7, pages 710-715.
Crossref
Rubén Queiro, Anahy Brandy, Mª Carmen Rosado, Andrés Lorenzo, Pablo Coto, Carmen Carriles, Mercedes Alperi & Javier Ballina. (2018) Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis. JCR: Journal of Clinical Rheumatology 24:7, pages 381-384.
Crossref
Ennio Lubrano, Silvia Scriffignano, Antonia De Socio, Mariateresa Mastrocinque & Fabio Massimo Perrotta. (2018) Composite Disease Activity Indices Tailored for Psoriatic Arthritis. Journal of Psoriasis and Psoriatic Arthritis 3:3, pages 94-99.
Crossref
Ennio Lubrano & Fabio Massimo Perrotta. (2017) Psoriatic arthritis: is it time to treat-to-target or target to treat?. Clinical Rheumatology 36:12, pages 2633-2635.
Crossref
Ennio Lubrano, Antonia De Socio & Fabio Massimo Perrotta. (2017) Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort. The Journal of Rheumatology 44:8, pages 1159-1164.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.